Other featured articles
Eli Lilly Is Cutting Insulin Prices and Capping Copays at $35 – 5 Questions Answered
The drugmaker’s move responded to the growing competition that has shaken up the insulin market in recent years.Posted in
Many Americans Wrongly Assume They Understand What Normal Blood Pressure Is – and That False Confidence Can Be Deadly
Nearly half of all Americans ages 20 and up have high blood pressure. Yet research shows that most people in the US don’t know the cutoff numbers for healthy blood.Posted in
Small Cannabis Producers Have Bigger Problems than State Taxes and Regulation
Removing regulations and taxes on cannabis sales would take away resources that are needed to address legitimate public health concerns and won’t solve the supply-side problem.Posted in
Hidden Physician Financial Conflicts of Interest in Dialysis
Nephrologists’ ownership of dialysis facilities doesn’t affect outcomes, but why is it so secret?Posted in
About this section
The Evidence Base focuses on improving policy in health, economics, and well-being. Learn More>
View all of the contributors to The Evidence Base here.
More from the Evidence Base Blog
National Survey Findings Shed Light on Dimensions of Teen Mental Health Concerns
We find evidence of worsening mental health since 2013 among both boys and girls.
CMS’s Alzheimer’s Coverage Policy Will Inhibit Access and Discourage Innovation
Individuals in underserved communities have to travel long distances, well beyond the 30-minute standard, to access clinical trial sites for Aduhelm.
During the Height of the Opioid Epidemic, the Out-of-Pocket Price of Naloxone Increased by Over 500%
A jump in the out-of-pocket price of naloxone has likely made the lifesaving drug too expensive for most uninsured Americans.
Bumpy Road Ahead for Lecanemab Approval
How to ensure lecanemab doesn’t wind up like aducanumab.
How to Protect Yourself Against Wildfire Smoke This Fire Season: Five Tips in Everyday Language
Helpful tips on staying protected from wildfire smoke.